<!DOCTYPE html>
<html lang="en">
<!-- Beautiful Jekyll 5.0.0 | Copyright Dean Attali 2020 -->
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">

  

  

  <link rel="shortcut icon" href="/img/lab_logo.ico">
  
  <title>Research</title>

  
  <meta name="author" content="Yu Lab @ USC Norris Comprehensive Cancer Center">
  

  <meta name="description" content="OUR VISION We are striving to unlock the power of the adaptive immune system to create next-generation immune therapeutics for cancer, autoimmunity, and infectious diseases. To do this, we will decode the dialogue of immune responses to develop protection that is as wide-ranging as possible, target and clear threats as...">

  

  

  
  <link rel="alternate" type="application/rss+xml" title="Yu Lab" href="http://localhost:4000/feed.xml">
  

  

  

  

  


  
    
      
  <link href="https://stackpath.bootstrapcdn.com/bootstrap/4.4.1/css/bootstrap.min.css" rel="stylesheet" integrity="sha384-Vkoo8x4CGsO3+Hhxv8T/Q5PaXtkKtu6ug5TOeNV6gBiFeWPGFN9MuhOf23Q9Ifjh" crossorigin="anonymous">


    
      
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css">


    
      
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Lora:400,700,400italic,700italic">


    
      
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans:300italic,400italic,600italic,700italic,800italic,400,300,600,700,800">


    
  

  
    
      <link rel="stylesheet" href="/assets/css/bootstrap-social.css">
    
      <link rel="stylesheet" href="/assets/css/beautifuljekyll.css">
    
  

  
    
      <link rel="stylesheet" href="/assets/css/custom-styles.css">
    
  

  
  
  

  

  
  <meta property="og:site_name" content="Yu Lab">
  <meta property="og:title" content="Research">
  <meta property="og:description" content="OUR VISION We are striving to unlock the power of the adaptive immune system to create next-generation immune therapeutics for cancer, autoimmunity, and infectious diseases. To do this, we will decode the dialogue of immune responses to develop protection that is as wide-ranging as possible, target and clear threats as...">

  

  
  <meta property="og:type" content="website">
  <meta property="og:url" content="http://localhost:4000/research/">
  <link rel="canonical" href="http://localhost:4000/research/">
  

  
  <meta name="twitter:card" content="summary">
  
  <meta name="twitter:site" content="@">
  <meta name="twitter:creator" content="@">

  <meta property="twitter:title" content="Research">
  <meta property="twitter:description" content="OUR VISION We are striving to unlock the power of the adaptive immune system to create next-generation immune therapeutics for cancer, autoimmunity, and infectious diseases. To do this, we will decode the dialogue of immune responses to develop protection that is as wide-ranging as possible, target and clear threats as...">

  <meta name="twitter:image" content="http://localhost:4000/img/twitter_image.png">

  


  

  

</head>


<body>
  


  <div style="margin-bottom: 0.7rem">
    <nav class="navbar navbar-expand-lg navbar-light fixed-top navbar-custom top-nav-regular"><a class="navbar-brand navbar-brand-logo" href="http://localhost:4000/"><img alt="Yu Lab Logo" src="/img/icon.png"/></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#main-navbar" aria-controls="main-navbar" aria-expanded="false" aria-label="Toggle navigation">
    <span class="navbar-toggler-icon"></span>
  </button>

  <div class="collapse navbar-collapse" id="main-navbar">
    <ul class="navbar-nav ml-auto">
          <li class="nav-item">
            <a class="nav-link" href="/index">Home</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="/research">Research</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="/team">Team</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="/publications">Publications</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="/news">News</a>
          </li>
          <li class="nav-item">
            <a class="nav-link" href="/joinus">Join Us</a>
          </li></ul>
  </div>

  

  

</nav>




  </div><img style='width: 100%' src=../img/research.png alt=""><!-- TODO this file has become a mess, refactor it -->






<div class=" container-fluid " role="main">
  <div class="row">
    <div class=" col ">
      

      <div class="container" align="justify">
  <p class="section_title">
    OUR VISION
  </p>
  <p>
    We are striving to unlock the power of the adaptive immune system to create next-generation
    immune therapeutics for cancer, autoimmunity, and infectious diseases. To do this, we will
    decode the dialogue of immune responses to develop protection that is as
    <mark class="highlighted-text">wide-ranging</mark> as
    possible, target and clear threats as <mark class="highlighted-text">specifically</mark>
    as possible, and evoke an optimal immune
    memory that is as <mark class="highlighted-text">durable</mark> as possible.
  </p>
    
  <p class="section_title">
    CURRENT RESEARCH
  </p>
  <p class="research_title" id="see" style="margin-top: -4rem; padding-top: 6rem;">
    Mapping T Cell-Tumor Recognition at the Single-Cell Level
  </p>
  <img src="../img/research1.png"
       style="max-width: 90%; width: 500px;margin-top: 1rem;"
       class="center">
  <p>
    Cytotoxic T cells are a key component of our immune system, capable of recognizing and attacking cancer
    cells without harming healthy cells. To develop personalized cancer immunotherapies, it is essential to
    identify the tumor neoantigens and paired T cell receptors (TCRs) in each patient. To this end, we have
    developed <a href="https://www.sciencedirect.com/science/article/pii/S009286742201460X" target="_blank">ENTER</a>,
    a viral platform that can map antigen specificity, TCR repertoire, and molecular phenotype
    of T cells at the single-cell level. Combining viral engineering, single-cell genomics, and high-throughput
    library screening, we will develop a suite of tools to answer the following questions:
  </p>
  <p style="margin-top: 1rem">
    <ol>
      <li style="margin-bottom: 1.5rem">
	How can we systematically identify the "immune-visible" tumor neoantigens to prioritize candidates for tumor neoantigen vaccine development?
      </li>
      <li style="margin-bottom: 1.5rem">
	How can we rapidly identify the tumor antigen-specific TCRs in a high-throughput manner to advance TCR-T cell adoptive transfer therapy for cancer patients?
      </li>
      <li style="margin-bottom: 1.5rem">
	How does tumor neoantigen specificity impact anti-tumor T cell fate and function?
      </li>
    </ol>
  </p>
  
  <p class="research_title" id="talk" style="margin-top: -4rem; padding-top: 6rem;">
    Deciphering Antigen-Specific T Cell Fate Decision in Response to External Cues
  </p>
  <img src="../img/research2.png"
       style="max-width: 90%; width: 500px; margin-top: 1rem;"
       class="center">
  <p>
    Beyond antigen specificity, environmental cues such as cytokine exposure or cell-cell communication,
    can modulate the molecular programming and functional diversity of antigen-specific T cells. Previously,
    we have deciphered the
    <a href="https://www.nature.com/articles/ni.3706" target="_blank">molecular blueprint of T cell precursors</a>
    upon infection via epigenetic and
    transcriptional profiling. By integrating epigenetic landscape and transcriptional network, we identified key
    <a href="https://www.nature.com/articles/ni.3706" target="_blank">transcription factors YY1 and NR3C1</a>
    that govern effector or memory precursor T cell decision, and
    further uncovered a unique role of
    <a href="https://www.nature.com/articles/nature24993" target="_blank">RUNX3 in T cell infiltration</a>
    in tumors. Our lab will combine CRISPR
    screen, epigenetic profiling and functional genomics to answer the following questions:
  </p>
  <p style="margin-top: 1rem">
    <ol>
      <li style="margin-bottom: 1.5rem">
	How do environmental cues reshape the epigenetic plasticity of T cells in tumors and infected tissues?
      </li>
      <li style="margin-bottom: 1.5rem">
	How can we identify key molecular drivers that fine-tune T cell behavior and fate decision?
      </li>
    </ol>
  </p>
  
  <p class="research_title" id="rewrite" style="margin-top: -4rem; padding-top: 6rem;">
    Developing Tools for Targeted Cargo Delivery for Precision Immunotherapeutics
  </p>
  <img src="../img/research3.png"
       alt="Developing tools in targeted cargo delivery for precision immunotherapeutics"
       style="max-width: 100%; width: 500px; margin-top: 1rem;"
       class="center">
  <p>
    The advancement of immunotherapy, such as immune checkpoint blockade, has revolutionized cancer treatment
    and improved the lives of many patients. However, this treatment can also cause Immune-Related Adverse
    Events (irAEs) due to overstimulation of self-reactive T cells, which attack healthy cells in the human
    body. To reduce the risk of irAEs in the next generation of immunotherapy, we will use
    <a href="https://www.sciencedirect.com/science/article/pii/S009286742201460X" target="_blank">ENTER</a>
    to develop delivery tools that specifically reinvigorate exhausted tumor-reactive T cells without activating
    self-reactive T cells. These tools will reshape the immune repertoire, paving the way for precision immunotherapy
    for cancer and autoimmunity.
  </p>

  <p class="research_title" id="xist" style="margin-top: -4rem; padding-top: 6rem;">
    Exploring X-inactivation maintenance in female-biased autoimmunity
  </p>
  <img src="../img/research4.png"
       style="max-width: 90%; width: 500px;margin-top: 1rem;"
       class="center">
  <p>
    Females, harboring two X chromosomes, exhibit a heightened immune response to infections, however are more prone
    to develop autoimmune diseases compared to males with one X chromosome.
    <a href="https://pubmed.ncbi.nlm.nih.gov/33735607" target="_blank">Our recent work</a>
    unveiled a critical role
    of female-specific lncRNA XIST in maintaining X-inactivation of key immune genes in B cells. We will further explore
    the molecular mechanism of X-inactivation maintenance in age-associated B cells, a subset that is abnormally expanded
    in patients with female-biased autoimmune diseases.
  </p>
  
  <p class="research_title" id="" style="margin-top: -2rem; padding-top: 6rem; font-weight: normal; font-size: 120%;">
    We are grateful for the funding support from sponsors who believe and invest in our research
  </p>
  <p>
    <img src="../img/funding.png"
	 alt=""
	 style="max-width: 100%; width: 500px; margin-top: 1rem;"
	 class="center">
  <p>
</div>




      

      

    </div>
  </div>
</div>


  <footer class="footer-min">
  <div class="row">
    <div class="col-xl-8 offset-xl-2 col-lg-10 offset-lg-1">
      <p class="copyright text-muted">
	
        Yu Lab @ USC Norris Comprehensive Cancer Center
        &nbsp;&bull;&nbsp;
	
	2024
	
	
	
	
	
	<p class="theme-by text-muted">
	<p class="center">
	  Powered by
	  <a href="https://beautifuljekyll.com">Beautiful Jekyll</a>
	</p>
	
      </div>
    </div>
  </div>
</footer>


  
  
    
  <script src="https://code.jquery.com/jquery-3.5.1.slim.min.js" integrity="sha256-4+XzXVhsDmqanXGHaHvgh1gMQKX40OUvDEBTu8JcmNs=" crossorigin="anonymous"></script>


  
    
  <script src="https://cdn.jsdelivr.net/npm/popper.js@1.16.0/dist/umd/popper.min.js" integrity="sha384-Q6E9RHvbIyZFJoft+2mJbHaEWldlvI9IOYy5n3zV9zzTtmI3UksdQRVvoxMfooAo" crossorigin="anonymous"></script>


  
    
  <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.4.1/js/bootstrap.min.js" integrity="sha384-wfSDF2E50Y2D1uUdj0O3uMBJnjuUD4Ih7YwaYd1iqfktj0Uod8GCExl3Og8ifwB6" crossorigin="anonymous"></script>


  



  
    <!-- doing something a bit funky here because I want to be careful not to include JQuery twice! -->
    
      <script src="/assets/js/beautifuljekyll.js"></script>
    
  









</body>
</html>
